Aurinia Pharmaceuticals, Inc. (AUPH)
15.61
+0.14
(+0.90%)
USD |
NASDAQ |
Apr 02, 16:00
15.70
+0.09
(+0.58%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap : 2.092B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xenon Pharmaceuticals, Inc. | 5.444B |
| Oncolytics Biotech, Inc. | 106.70M |
| Edesa Biotech, Inc. | 56.70M |
| Lexaria Bioscience Corp. | 30.78M |
| ProMIS Neurosciences, Inc. | 26.10M |
Market Cap Related Metrics
| PE Ratio | 7.515 |
| PS Ratio | 7.650 |
| PEG Ratio | 0.0014 |
| Price to Book Value | 3.571 |
| Price to Free Cash Flow | 15.96 |
| Price | 15.61 |
| Earnings Yield | 13.31% |
| PEGY Ratio | 0.0014 |
| Operating PE Ratio | 18.65 |
| Normalized PE Ratio | 7.486 |